Liver cancer has the fourth highest mortality rate of all cancers worldwide, with
hepatocellular carcinoma (HCC) being the most prevalent subtype. Despite great advances …

Hepatocellular carcinoma (HCC) is one of most common cancers and the fourth leading
cause of death worldwide. Commonly, HCC development occurs in a liver that is severely …

Hepatocellular Carcinoma (HCC) is a highly prevalent malignancy that develops in patients
with chronic liver diseases and dysregulated systemic and hepatic immunity. The tumor …

Simple Summary Hepatocellular carcinoma (HCC) is a leading cause of cancer-related
death worldwide with slow progress in the development of effective therapies. The …

Hepatocellular carcinoma (HCC) presents significant treatment challenges despite
considerable advancements in its management. The Indian National Association for the …

Simple Summary Hepatocellular carcinoma (HCC) is the most common primary hepatic
malignancy, with increasing incidence over the past several decades. The majority of …

Hepatocellular carcinoma (HCC) is a common complication in patients with chronic liver
disease and leads to significant morbidity and mortality. Liver disease and liver cancer are …

Simple Summary Advanced hepatocellular carcinoma (HCC) carries a grim prognosis,
which has historically been compounded by a lack of available systemic therapies …

Hepatocellular carcinoma (HCC) is a leading cause of cancer-associated mortality
worldwide. HCC is an inflammation-associated immunogenic cancer that frequently arises in …

This study aimed to investigate the clinical characteristics of patients with unresectable
hepatocellular carcinoma (HCC), who were eligible for sequential systemic therapy. We …